Friday - October 13, 2017
World Health Summit 2017 in Berlin:

Bayer foundations bring tech pioneers, physicians and social entrepreneurs to the World Health Summit

The World Health Summit is considered the most important strategic forum for global health issues, with more than 2000 participants from over 100 countries / At “The Beauty of Impact” panel, the Bayer Cares Foundation presents social entrepreneurs who are working on new solutions for major global health problems

Leverkusen, October 13, 2017 – The World Health Summit will be held on October 15-17, 2017, in Berlin under the patronage of German Chancellor Angela Merkel, French President Emmanuel Macron and European Commission President Jean-Claude Juncker. Key topics this year are health policy in the G7/G20, new vaccine research and development, digitalization and big data, health security, urban health, and Africa and the United Nations' sustainability goals. This year’s speakers include seven government ministers from six countries, two Nobel laureates, and CEOs of businesses and NGOs – including Werner Baumann, Chairman of the Board of Management of Bayer AG.

The Bayer foundations have been supporting the World Heath Summit since 2014 with financial sponsorship in the form of participant stipends in the Young Physician Leaders (YPL) Program and with subject-matter expertise in dialog events. YPL alumnus Dr. Kalana Maduwage’s project is a particularly impressive success story. The physician, scientist, social entrepreneur and snake expert from Sri Lanka took part in the summit last year as a Bayer stipend recipient and garnered enthusiasm with a unique innovation. In his home country alone, around 80,000 farmers are bitten by snakes in their fields every year. The doctors there face a real dilemma: there is never enough antivenom available to treat all of the patients, but anyone receiving treatment too late has little chance of a successful recovery. Maduwage recognized this dilemma from his own work as a physician and is currently working on developing a fast enzyme-based test to determine the actual concentration of snake venom in a patient's blood. In the future, doctors will be able to administer the limited medication in a targeted way and save many patients.

The Bayer Cares Foundation has nominated the project for the 2017 Aspirin Social Innovation Award and will present it, along with other groundbreaking ideas, as part of “The Beauty of Impact” panel at the World Health Summit 2017. The Bayer foundations' lineup will include the social entrepreneur and founder of Discovering Hands, Dr. Frank Hoffmann, who is training blind women to perform breast examinations, as well as Martin Aufmuth, the founder of OneDollarGlasses, a charitable company that produces spectacles for one dollar, with the goal of enabling everyone all over the world to purchase spectacles when needed.

The entire World Health Summit is open to the media:

Find more information at:

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Download Center
file(s) collected

View Download Center